

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | PDE ↓ ↑ | PDE1 ↓ ↑ | PDE10A ↓ ↑ | PDE2 ↓ ↑ | PDE3 ↓ ↑ | PDE4 ↓ ↑ | PDE5 ↓ ↑ | PDE6 ↓ ↑ | 其他靶点 | 纯度 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Doxofylline | ✔ | 99+% | |||||||||||||||||
| Deltarasin |
+++
PDEδ , Kd: 38 nM |
95% | |||||||||||||||||
| 7-(2,3-Dihydroxypropyl)theophylline | ✔ | 98% | |||||||||||||||||
| Aminophylline |
+
PDE, IC50: 0.12 mM |
98+% | |||||||||||||||||
| Anagrelide HCl | ✔ | 99%+ | |||||||||||||||||
| Irsogladine | ✔ | AChR,mAChR | 99% | ||||||||||||||||
| PF-8380 |
+++
Autotaxin, IC50: 2.8 nM |
99%+ | |||||||||||||||||
| Dipyridamole | ✔ | 98% | |||||||||||||||||
| Balipodect |
++++
PDE10A, IC50: 0.3 nM |
99%+ | |||||||||||||||||
| Luteolin |
+
PDE1, Ki: 15.0 μM |
++
PDE2, Ki: 6.4 μM |
+
PDE3, Ki: 13.9 μM |
+
PDE4, Ki: 11.1 μM |
+
PDE5, Ki: 9.5 μM |
98% | |||||||||||||
| Milrinone |
++
PDE2, IC50: 5.2 μM |
++
PDE3, IC50: 2.1 μM |
ATPase | 99% | |||||||||||||||
| Pimobendan |
++
PDE3, IC50: 0.32 μM |
98% | |||||||||||||||||
| Cilostazol |
++
PDE3, IC50: 0.2 μM |
98% | |||||||||||||||||
| Fenspiride HCl |
+
PDE3, pIC50: 3.44 |
+
PDE4, pIC50: 4.16 |
99% (HPLC) | ||||||||||||||||
| (S)-(+)-Rolipram |
++
PDE4, IC50: 0.75 μM |
99% (HPLC) | |||||||||||||||||
| Apremilast |
+++
PDE4, IC50: 74 nM |
98% | |||||||||||||||||
| GSK256066 |
++++
PDE4B, IC50: 3.2 pM |
98+% | |||||||||||||||||
| Roflumilast |
++++
PDE4A1, IC50: 0.7 nM PDE4A4, IC50: 4.3 nM |
99% | |||||||||||||||||
| Rolipram |
+++
PDE4B, IC50: 130 nM |
99%+ | |||||||||||||||||
| Cilomilast |
+++
LPDE4, IC50: 100 nM HPDE4, IC50: 120 nM |
99% | |||||||||||||||||
| Avanafil |
++++
PDE5, IC50: 1 nM |
98% | |||||||||||||||||
| Vardenafil HCl Trihydrate |
++++
PDE5, IC50: 0.7 nM |
98% | |||||||||||||||||
| Tadalafil |
++++
PDE5, IC50: 1.8 nM |
98% | |||||||||||||||||
| Icariin |
++
PDE5, IC50: 0.432 μM |
98% | |||||||||||||||||
| Sildenafil | ✔ |
+++
PDE6, IC50: 33 nM |
98% | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Phosphodiesterase-5 (PDE5) is a homodimer that belongs to mammalian PDE family. The catalytic domain of PDE5 catalyzes the breakdown of cGMP to 5’-GMP. Tadalafil is a PDE5 inhibitor with an IC50 value of 1.8 0.4nM. The stoichiometry of [3H]Tadalafil binding to PDE5 was 0.68 0.10 mol/subunit. The KD (isotherm), KD (dissociation rate), and KD (1/2 EC50) values of tadalafil against PDE5 were 2.4 0.60, 1.9 0.37, and 2.7 0.25nM, respectively[5]. Tadalafil also inhibits human cytochrome P450 (CYPs) with Ki values of 41 5, 66 6, 73 8, and 14 1μM against CYP3A-, CYP2C9-, CYP2C19-, and CYP1A2-mediated metabolism, respectively. Tadalafil at the dose of 1μM or greater induced the protein level of CYP3A in hepatocytes. The CYP3A activity was increased by 1μM tadalafil, but this induction was suppressed after the exposure to 10μM tadalafil. Also in hepatocyte cultures, the exposure to 0.1 – 1μM tadalafil slightly inhibited CYP3A-mediated midazolam 1’-hydroxylase activity. With the treatment of 10μM tadalafil, 1’-OH-midazolam formation was significantly inhibited in a time-dependent manner[6]. In mice subjected to cavernous nerve resection, treatment with tadalafil (1.3 gm per day) via oral gavage for 20 days decreased the number of apoptotic cells and increased the phosphorylation of the 2 survival associated kinases, Akt and extracellular signal-regulated kinase 1/2[7]. |
| 作用机制 | Tadalafil inhibits PDE5 by specifically binding to the catalytic site of PDE5[5]. |
| Concentration | Treated Time | Description | References | |
| Plasmodium falciparum gametocyte-infected erythrocytes | 100 µM | 30 minutes | To investigate the effect of Tadalafil on mature GIE, results showed that Tadalafil-treated GIE were cleared faster from the peripheral blood and retained more in the spleen. | Front Cell Infect Microbiol. 2022 May 25;12:883759. |
| Raw264.7 macrophages | 25 µM | 48 hours | TA significantly suppressed M2 polarization and promoted M1 polarization | J Immunother Cancer. 2023 Feb;11(2):e006493. |
| Primary macrophages from mice | 25 µM | 48 hours | TA significantly suppressed M2 polarization and promoted M1 polarization | J Immunother Cancer. 2023 Feb;11(2):e006493. |
| MDA-MB-231 cells | 50, 100, 150 µM | 48 hours | To detect the total protein levels of H4R3me2s and H3R8me2s, the results showed that compounds A, B, C, and Tadalafil reduced the total levels of H4R3me2s and H3R8me2s in the cells in a dose-dependent manner, with compound A having the strongest effect. | Int J Mol Sci. 2022 Apr 27;23(9):4806. |
| MCF-7 cells | 150 µM | 48 hours | To detect cell proliferation, the results showed that compound A had the strongest inhibitory effect on MCF-7 cell proliferation at 150 μM. | Int J Mol Sci. 2022 Apr 27;23(9):4806. |
| HCC1937 cells | 150 µM | 48 hours | To detect cell proliferation, the results showed that compound A had the strongest inhibitory effect on HCC1937 cell proliferation at 150 μM. | Int J Mol Sci. 2022 Apr 27;23(9):4806. |
| Administration | Dosage | Frequency | Description | References | ||
| Wistar Albino rats | Alcohol-induced gastric ulcer model | Oral | 10 mg/kg | Single dose, lasting 1 hour | To evaluate the gastroprotective effect of Tadalafil against alcohol-induced gastric ulcers, the results showed that Tadalafil significantly reduced the ulcer area and ulcer index. | Int J Nanomedicine. 2020 Dec 14;15:10099-10112 |
| C57/B6 mice | L-NAME-induced preeclampsia and fetal growth restriction model | Oral | 13.9 ± 1.9 mg/kg BW/day | From day 14 to day 17 of pregnancy, daily administration | Tadalafil treatment improved neurodevelopment in FGR offspring, reduced the expression of hypoxia marker HIF-2α in the placenta and fetal brain, and improved synaptogenesis and myelination in offspring on P15 and P30. | Sci Rep. 2019 Jan 18;9(1):234 |
| C57BL/6 mice | Orthotopic HCC model | Tail vein injection | 2 mg/kg | Not specified | TA reversed the immunosuppressive TME by regulating M2 TAMs and MDSCs | J Immunother Cancer. 2023 Feb;11(2):e006493. |
| Nude mice | MDA-MB-231 xenograft model | Gastric gavage | 2 mg/kg | Once daily for 21 days | To evaluate the effect of compound A on tumor growth, the results showed that compound A alone slowed tumor growth and further enhanced the efficacy of chemotherapeutics when used in combination. | Int J Mol Sci. 2022 Apr 27;23(9):4806. |
| Rats | Fructose-fed rat model | Gavage | 2 mg/kg | Once daily for four weeks | Tadalafil ameliorated chronic ischemia-associated bladder overactivity by promoting pelvic angiogenesis and enhancing p-eNOS expression. | Int J Mol Sci. 2025 Feb 6;26(3):1363 |
| NSG mice | Humanized mouse model | Oral | 8 mg/kg | Once daily for 4 days | To investigate the effect of Tadalafil on the circulation of mature GIE in vivo, results showed that Tadalafil treatment significantly reduced the presence of GIE in the circulation and promoted their accumulation in the spleen. | Front Cell Infect Microbiol. 2022 May 25;12:883759. |
| Dose | Mice: 60 mg/kg - 400 mg/kg[3] (p.o.) Rat: 5 mg/kg[4] (retrolingually), 10 mg/kg - 400 mg/kg[3] (p.o.) |
| Administration | p.o., retrolingually |
| Pharmacokinetics |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.57mL 0.51mL 0.26mL |
12.84mL 2.57mL 1.28mL |
25.68mL 5.14mL 2.57mL |
|
| CAS号 | 171596-29-5 |
| 分子式 | C22H19N3O4 |
| 分子量 | 389.4 |
| SMILES Code | O=C([C@@]1([H])CC2=C([C@@H](C3=CC=C(OCO4)C4=C3)N15)NC6=C2C=CC=C6)N(C)CC5=O |
| MDL No. | MFCD07771966 |
| 别名 | 他达那非;西力士 ;IC-351 |
| 运输 | 蓝冰 |
| InChI Key | WOXKDUGGOYFFRN-IIBYNOLFSA-N |
| Pubchem ID | 110635 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 50 mg/mL(128.4 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1